Literature DB >> 24252497

Usefulness and limitations of single-slice computed tomography analysis at the third lumbar region in the assessment of sarcopenia.

Vildan Binay Safer, Umut Safer.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24252497      PMCID: PMC4057438          DOI: 10.1186/cc13123

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

In the previous issue of Critical Care, Moisey and colleagues [1] report that sarcopenia has potential to serve as a predictor for mortality, discharge disposition, and ICU utilization. Sarcopenia may be mitigated by adequate nutrition supply and early rehabilitation, and so identification of patients with ICU-acquired weakness, who could benefit from rehabilitation, is of fundamental importance [2]. Sarcopenia diagnosis is based on estimation of muscle mass. Whole-body imaging methods like computed tomography (CT) and magnetic resonance imaging (MRI) can precisely measure muscle mass, but limitations of these modalities led to new tools for daily practice. The European Working Group on Sarcopenia in Older People (EWGSOP) recommends the use of dual-energy x-ray absorptiometry (DXA) as an alternative [3]. Nowadays, single-slice CT image analysis, which was used in the study by Moisey and colleagues, is becoming a popular alternative. Validation of this technique was previously assessed by comparing the single-slice CT analysis at the third lumbar (L3) region with DXA, which is not the gold standard [4]. Measurement errors related to DXA might affect these validation results. Although Shen and colleagues [5] compared single-slice CT analysis and whole-body MRI, they reported results for the fourth-fifth lumbar region, not for the L3 region. Moreover, this study was conducted among healthy subjects and this limited the generalization of results for the ICU setting. The EWGSOP recommends the measurement of muscle power, function, and mass for a sarcopenia diagnosis [3]. As muscle function and power data of patients were not reported in the present article, we do not know whether all participants were accurately classified as sarcopenic.

Authors’ response

Marina Mourtzakis, Lesley Moisey, Daren Heyland and Rosemary Kozar. We appreciate the interest of Binay Safer and Safer in our article.

Definition of sarcopenia

The EWGSOP recommends that sarcopenia be defined as low muscularity as well as loss of muscle strength or performance or both [1], necessitating advances in precisely measuring muscle mass. The authors correctly indicate that we did not measure muscle strength/performance. However, our study was performed on critically injured, older trauma patients at the time of admission, prohibiting any meaningful assessment of muscle strength. We present a novel approach that is highly accessible and practical as CT scans are frequently performed as part of routine care for the injured patient. Our aim goes beyond categorizing sarcopenic versus non-sarcopenic patients to show differences in various clinical outcomes (note that muscle, as a continuous variable, is also associated with mortality) [2]. Our ultimate goal is to identify vulnerable patients who require specific nutritional or rehabilitative intervention and assess success or failure of this intervention by using CT. CT imaging is one of a few modalities that measure muscle specifically and is far superior to body weight (most commonly used to measure nutritional status in the ICU). Single-slice CT images in the lumbar region (including L3) have been strongly associated with whole-body muscle volume by using MRI in healthy people [3] and DXA in a clinical population [4], indicating that lumbar muscle is representative of whole-body muscle.

Computed tomography versus dual-energy x-ray absorptiometry

When CT and MRI are not available, DXA is recommended by the EWGSOP as an alternative method. DXA is not always available, accessible, practical, or feasible for critically injured patients. Transporting these patients for additional studies carries risk and does incur additional cost. Importantly, DXA measures lean body mass, which includes skeletal muscle as well as internal organs such as liver and spleen that may be confounding during critical illness. Isolating appendicular muscle is possible but requires some manual analysis and may introduce human error.

Abbreviations

CT: Computed tomography; DXA: Dual-energy x-ray absorptiometry; EWGSOP: European Working Group on Sarcopenia in Older People; L3: Third lumbar; MRI: Magnetic resonance imaging.

Competing interests

The authors declare that they have no competing interests.
  5 in total

1.  Intensive care unit acquired muscle weakness: when should we consider rehabilitation?

Authors:  Zudin Puthucheary; Nicholas Hart
Journal:  Crit Care       Date:  2009-07-20       Impact factor: 9.097

2.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

3.  Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image.

Authors:  Wei Shen; Mark Punyanitya; ZiMian Wang; Dympna Gallagher; Marie-Pierre St-Onge; Jeanine Albu; Steven B Heymsfield; Stanley Heshka
Journal:  J Appl Physiol (1985)       Date:  2004-08-13

4.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.

Authors:  Marina Mourtzakis; Carla M M Prado; Jessica R Lieffers; Tony Reiman; Linda J McCargar; Vickie E Baracos
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

5.  Skeletal muscle predicts ventilator-free days, ICU-free days, and mortality in elderly ICU patients.

Authors:  Lesley L Moisey; Marina Mourtzakis; Bryan A Cotton; Tahira Premji; Daren K Heyland; Charles E Wade; Eileen Bulger; Rosemary A Kozar
Journal:  Crit Care       Date:  2013-09-19       Impact factor: 9.097

  5 in total
  6 in total

1.  Comment on: Preoperative Sarcopenia Strongly Influences the Risk of Postoperative Pancreatic Fistula Formation After Pancreaticoduodenectomy.

Authors:  Umut Safer; Cem Haymana; Vildan Binay Safer
Journal:  J Gastrointest Surg       Date:  2016-10-13       Impact factor: 3.452

2.  Comment on: sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer-results from the ABLE feasibility trial.

Authors:  Irem Kirac Utku; Umut Safer
Journal:  Breast Cancer Res Treat       Date:  2022-01-07       Impact factor: 4.872

3.  Comment on "Sarcopenia as a Predictor of Survival in Patients with Pancreatic Adenocarcinoma After Pancreatectomy".

Authors:  Ayfer Durak; Umut Safer
Journal:  Ann Surg Oncol       Date:  2022-03-16       Impact factor: 5.344

4.  Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial.

Authors:  Manon Gouez; Olivia Pérol; Maurice Pérol; Christophe Caux; Christine Ménétrier-Caux; Marine Villard; Thierry Walzer; Lidia Delrieu; Pierre Saintigny; Philippe Marijnen; Vincent Pialoux; Béatrice Fervers
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

5.  Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines.

Authors:  Federica Mazzuca; Concetta Elisa Onesti; Michela Roberto; Marco Di Girolamo; Andrea Botticelli; Paola Begini; Lidia Strigari; Paolo Marchetti; Maurizio Muscaritoli
Journal:  Oncotarget       Date:  2018-05-22

Review 6.  Measuring Muscle Mass and Strength in Obesity: a Review of Various Methods.

Authors:  Dionne Sizoo; Loek J M de Heide; Marloes Emous; Tim van Zutphen; Gerjan Navis; André P van Beek
Journal:  Obes Surg       Date:  2020-11-06       Impact factor: 4.129

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.